These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19010781)

  • 61. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
    Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F
    J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mercury(II) promotes the in vitro aggregation of tau fragment corresponding to the second repeat of microtubule-binding domain: Coordination and conformational transition.
    Yang DJ; Shi S; Zheng LF; Yao TM; Ji LN
    Biopolymers; 2010 Dec; 93(12):1100-7. PubMed ID: 20665688
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A thiol-based intramolecular redox switch in four-repeat tau controls fibril assembly and disassembly.
    Weismiller HA; Holub TJ; Krzesinski BJ; Margittai M
    J Biol Chem; 2021 Sep; 297(3):101021. PubMed ID: 34339733
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.
    KrishnaKumar VG; Paul A; Gazit E; Segal D
    Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice.
    Baker S; Polanco JC; Götz J
    J Alzheimers Dis; 2016 Oct; 54(3):1207-1217. PubMed ID: 27567840
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Can any "non-specific charge modification within microtubule binding domains of Tau" be a prerequisite of the protein amyloid aggregation? An in vitro study on the 1N4R isoform.
    Jangholi A; Ashrafi-Kooshk MR; Arab SS; Karima S; Poorebrahim M; Ghadami SA; Moosavi-Movahedi AA; Khodarahmi R
    Int J Biol Macromol; 2018 Apr; 109():188-204. PubMed ID: 29248553
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of lysine residues on structural characteristics and stability of tau proteins.
    Lee M; Baek I; Choi H; Kim JI; Na S
    Biochem Biophys Res Commun; 2015 Oct; 466(3):486-92. PubMed ID: 26381172
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanistic and Structural Origins of the Asymmetric Barrier to Prion-like Cross-Seeding between Tau-3R and Tau-4R.
    Kumar H; Udgaonkar JB
    J Mol Biol; 2018 Dec; 430(24):5304-5312. PubMed ID: 30267747
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species.
    Nachman E; Wentink AS; Madiona K; Bousset L; Katsinelos T; Allinson K; Kampinga H; McEwan WA; Jahn TR; Melki R; Mogk A; Bukau B; Nussbaum-Krammer C
    J Biol Chem; 2020 Jul; 295(28):9676-9690. PubMed ID: 32467226
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
    Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
    Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Distinct Therapeutic Mechanisms of Tau Antibodies: Promoting Microglial Clearance Versus Blocking Neuronal Uptake.
    Funk KE; Mirbaha H; Jiang H; Holtzman DM; Diamond MI
    J Biol Chem; 2015 Aug; 290(35):21652-62. PubMed ID: 26126828
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure.
    von Bergen M; Barghorn S; Li L; Marx A; Biernat J; Mandelkow EM; Mandelkow E
    J Biol Chem; 2001 Dec; 276(51):48165-74. PubMed ID: 11606569
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes.
    Connell JW; Gibb GM; Betts JC; Blackstock WP; Gallo J; Lovestone S; Hutton M; Anderton BH
    FEBS Lett; 2001 Mar; 493(1):40-4. PubMed ID: 11278002
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Morphology of self-assembled structures formed by short peptides from the amyloidogenic protein tau depends on the solvent in which the peptides are dissolved.
    Chaudhary N; Singh S; Nagaraj R
    J Pept Sci; 2009 Oct; 15(10):675-84. PubMed ID: 19714684
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inert and seed-competent tau monomers suggest structural origins of aggregation.
    Mirbaha H; Chen D; Morazova OA; Ruff KM; Sharma AM; Liu X; Goodarzi M; Pappu RV; Colby DW; Mirzaei H; Joachimiak LA; Diamond MI
    Elife; 2018 Jul; 7():. PubMed ID: 29988016
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells.
    Vogelsberg-Ragaglia V; Bruce J; Richter-Landsberg C; Zhang B; Hong M; Trojanowski JQ; Lee VM
    Mol Biol Cell; 2000 Dec; 11(12):4093-104. PubMed ID: 11102510
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
    Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
    Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Missense point mutations of tau to segregate with FTDP-17 exhibit site-specific effects on microtubule structure in COS cells: a novel action of R406W mutation.
    Sahara N; Tomiyama T; Mori H
    J Neurosci Res; 2000 May; 60(3):380-7. PubMed ID: 10797541
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phosphorylation modulates the alpha-helical structure and polymerization of a peptide from the third tau microtubule-binding repeat.
    Mendieta J; Fuertes MA; Kunjishapatham R; Santa-María I; Moreno FJ; Alonso C; Gago F; Muñoz V; Avila J; Hernández F
    Biochim Biophys Acta; 2005 Jan; 1721(1-3):16-26. PubMed ID: 15652175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.